2781 - 2790 of 7916 Results
Title
Year
- Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting2021OPENTitle: Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meetingJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00868-7Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-021-00868-7Citation Count: 1
- Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression2021OPENTitle: Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2444End Page: 2446Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28715Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530949Citation Count: 31
-
RESTRICTEDTitle: Telemedicine and Deep brain stimulation - Current practices and recommendationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 199End Page: 205Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.001Citation Count: 22
-
RESTRICTEDTitle: Asymmetry at Disease Onset Is Not a Predictor of Parkinson’s Disease ProgressionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1689End Page: 1694Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-202525Citation Count: 6
- Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based Nosology2021OPENTitle: Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based NosologyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 14Start Page: 7292End Page: 7292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22147292Best OA location URL: https://www.mdpi.com/1422-0067/22/14/7292/pdf?version=1626760200Citation Count: 7
- Parkinson’s Disease Motor Symptom Progression Slowed with Multisensory Dance Learning over 3-Years: A Preliminary Longitudinal Investigation2021OPENTitle: Parkinson’s Disease Motor Symptom Progression Slowed with Multisensory Dance Learning over 3-Years: A Preliminary Longitudinal InvestigationJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 7Start Page: 895End Page: 895Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11070895Best OA location URL: https://www.mdpi.com/2076-3425/11/7/895/pdf?version=1625647210Citation Count: 19
- Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and Falling2021OPENTitle: Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and FallingJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1957End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212636Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212636?id=journal-of-parkinsons-disease%2Fjpd212636Citation Count: 11
-
OPENTitle: Prescribing Aducanumab in the Face of Meager Efficacy and Real RisksJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 11Start Page: 545End Page: 547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012452Best OA location URL: https://n.neurology.org/content/neurology/97/11/545.full.pdfCitation Count: 28
- Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesis2021RESTRICTEDTitle: Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesisJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 9Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.816Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262606Citation Count: 1
- TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease2021OPENTitle: TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00200-yBest OA location URL: https://www.nature.com/articles/s41531-021-00200-y.pdfCitation Count: 4